EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy

Mohammad Faysal Al Mazid iD, Olha Shkel, Eunteg Ryu, Jiwon Kim, Kyung Ho Shin, Yun Kyung Kim iD, Hyun Suk Lim iD, Jun-Seok Lee iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00536 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Mohammad Faysal Al Mazid and 7 co-authors. Institution: Division of Bio-Medical Science and Technology, Korea Institute of Science and Technology (KIST) & Department of Biological Chemistry, KIST School US…. Major MEDLINE topics: Proteolysis, RNA-Binding Proteins, Aptamers, Nucleotide, Phosphoproteins. Cited 5 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Research Council of Science and Technology, National Research Foundation of Korea.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Target protein degradation (TPD) is a promising strategy for catalytic downregulation of target proteins through various cellular proteolytic pathways. Despite numerous reports on novel TPD mechanisms, the discovery of target-specific ligands remains a major challenge. Unlike small-molecule ligands, aptamers offer significant advantages, owing to their SELEX-based systematic screening method. To fully utilize aptamers for TPD, we designed an aptamer and N-degron ensemble system (AptaGron) that circumvents the need for synthetic conjugations between aptamers and proteolysis-recruiting units. In our AptaGron system, a peptide nucleic acid containing an N-degron peptide and a sequence complementary to the aptamer was designed. Using this system, we successfully degraded three target proteins, tau, nucleolin, and eukaryotic initiation factor 4E (eIF4E), which lack specific small-molecule ligands. Our results highlight the potential of the AptaGron approach as a robust platform for targeted protein degradation.

Subjects

MeSH terms (MEDLINE)

ProteolysisRNA-Binding ProteinsAptamers, NucleotidePhosphoproteinsEukaryotic Initiation Factor-4EHumanstau ProteinsNucleolinSELEX Aptamer TechniqueDegrons

Substances

RNA-Binding ProteinsAptamers, NucleotidePhosphoproteinsEukaryotic Initiation Factor-4Etau ProteinsNucleolin

Authors and institutions

  • Division of Bio-Medical Science and Technology, Korea Institute of Science and Technology (KIST) & Department of Biological Chemistry, KIST School UST, Seoul 02792, South Korea.
  • Department of Pharmacology, College of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, South Korea.
  • Brain Science Institute, Korea Institute of Science and Technology (KIST) & Department of Biological Chemistry, KIST School UST, Seoul 02792, South Korea.
  • Department of Chemistry, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang 37673, South Korea.

ORCID profiles: Mohammad Faysal Al Mazid, Yun Kyung Kim, Hyun Suk Lim, Jun-Seok Lee

Funding

  • National Research Council of Science and Technology
  • National Research Foundation of Korea

Cite

APA

Al Mazid, M. F., Shkel, O., Ryu, E., Kim, J., Shin, K. H., Kim, Y. K., Lim, H. S., & Lee, J. S. (2024). Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00536

Vancouver

Al Mazid MF, Shkel O, Ryu E, Kim J, Shin KH, Kim YK, et al. Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00536

BibTeX
@article{AlMazid2024,
  author = {Al Mazid, Mohammad Faysal and Shkel, Olha and Ryu, Eunteg and Kim, Jiwon and Shin, Kyung Ho and Kim, Yun Kyung and Lim, Hyun Suk and Lee, Jun-Seok},
  title = {Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00536}
}
Start for free →